Autonomix reports pancreatic cancer pain relief across all stages in PoC study at ASCO GI 2026

Autonomix Medical, Inc.

Rapid pain reduction within 24 hours of transvascular RF denervation procedure.
At 7 days, 93.75% of responding patients (N=16) improved from severe to mild/moderate pain.
At 4-6 weeks, ~2/3 of responders (N=9) maintained mild or eliminated pain levels.
At 3 months, no responders (N=6) had severe pain; 50% maintained mild or eliminated pain.
Even late-stage (Stage 4) patients showed meaningful early improvement despite disease progression.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.